Innovative Tissue-Based Diagnostics is designed to feature recent breakthroughs in the field of pathology such as testing for predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc. The goal of the conference is to enhance knowledge and experience exchange among industry and research pathologists as well as other researchers working with human tissue. This meeting will highlight the new generation of tissue-based diagnostic technologies aimed primarily towards molecular diagnostics of cancer. In addition, a session dedicated to the fascinating field of in vivo pathology will be offered.
KEY TAKE AWAYS:
• Learn about pathology's contribution and role in cancer drug development
• Get updates on how cancer pathology helps create genetically informed cancer medicine
• Learn how next generation sequencing has revolutionized genomics and is now on the verge of being widely adopted for medical sequencing
• Hear insights into in vivo microscopy and intra-operative optical imaging – a fascinating new and rapidly developing field of diagnostic medicine
• Get instructed on the challenges and solutions in assay development for the clinical setting
SESSIONS:
• Pathology in Cancer Drug Development
• Molecular Pathology as the Driving Force for Personalized Oncology
• Bridging Radiology-Pathology Divide
KEYNOTE PRESENTATIONS BY:
Pathology Contributions to Pharma R&D: Enabling Key Intersections between Scientific Discovery and Tissue Diagnostics
John Lowe, M.D., Senior Director of Pathology, Genentech
Strategies for Routine, Large Scale Clinical Genotyping of Lung Cancers for Optimal Selection of Targeted Therapies
Marc Ladanyi, M.D., The William Ruane Chair in Molecular Oncology, Attending Pathologist, Molecular Diagnostics Service, and Member, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center
Endoscopic Microscopy: Bridging the Radiology- Pathology Divide
Guillermo Tearney, M.D., Ph.D., Professor of Pathology, Harvard Medical School; Associate Director, Wellman Center for Photomedicine, Massachusetts General Hospital
|
Monday, June 4 • 9:00 am-12:00 pm
Massively parallel or “next generation” DNA sequencing has finally made its way into clinical laboratory. It is, however, associated with some currently unresolved issues such as handling the massive amounts of data produced, distinguishing benign variants from pathologic mutations as well as interpreting them. The topics to be discussed include but are not limited to:
- Technical aspects of next-generation sequencing
- Available instruments and laboratory solutions
- Statistical and computational challenges in next-generation sequencing
- New challenges in test interpretation and genetic counseling
- Coding and reimbursement
- Potential applications in cancer, genetic disorders, and infectious diseases
Instructors:
Madhuri Hegde, Ph.D., FACMG, Associate Professor, Senior Director, Emory Genetics Laboratory, Department of Human Genetics, Emory University School of Medicine.
Birgit Funke, PhD, FACMG, Assistant Professor of Pathology, MGH/Harvard Medical School, Director Clinical Research and Development, Laboratory for Molecular Medicine, Partners HealthCare Center for Personalized Genetic Medicine.
Click here for a more detailed agenda
*A separate registration is required.
|
